Brief: PainReform Announces Initial Topline Data For PRF-110 Phase 3 Clinical Trial
20/11/2024 13:34
Nov 20 (Reuters) - PainReform Ltd PRFX.O :
* PAINREFORM ANNOUNCES INITIAL TOPLINE DATA FOR PRF-110
PHASE 3
CLINICAL TRIAL
* PAINREFORM LTD - PRF-110 SHOWS STATISTICALLY SIGNIFICANT
PAIN
REDUCTION IN FIRST 48 HOURS
* PAINREFORM LTD - DATA FOR SUBSEQUENT 24-HOUR PERIOD
UNCLEAR DUE
TO INCOHERENCE
* PAINREFORM LTD - COLLABORATING WITH LOTUS TO RESOLVE DATA
INCOHERENCE
Source text: ID:nGNX3BBYs
Further company coverage: PRFX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PRF Technologies
See all newsBrief: Prf Technologies S.H.N. Financial Investments Seeks Special General Meeting At Prf Technologies To Remove Directors, Appoint Three S.H.N. Nominees
U.S. STOCKS ON THE MOVE-Bumble, Tempus AI, TD Synnex
U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
PRF Technologies rises as animal study shows pain drug matches approved rival
U.S. STOCKS ON THE MOVE-Wendy's, Canadian Solar, Bio-Techne